J Mikuła-Pietrasik, A Witucka, M Pakuła… - Cellular and Molecular …, 2019 - Springer
One of the most neglected aspects of chemotherapy are changes, and possible consequences of these changes, that occur in normal somatic cells. In this review, we …
T Gómez-Sierra, D Eugenio-Pérez… - Food and Chemical …, 2018 - Elsevier
Cancer is a relevant public health problem that represents the second leading cause of global death. In this regard, cisplatin is a highly effective antineoplastic drug used in …
Despite the enormous advances made in the field of oncology, no solution to the side effect of nephrotoxicity caused by cisplatin used as an antineoplastic agent for approximately 40 …
Cisplatin (CP), an effective chemotherapeutic drug, has been widely used to treat the several types of tumors. Orientin (ORI) is a flavonoid that shows versatile therapeutic …
SL Garcia, J Lauritsen, Z Zhang, M Bandak… - JNCI Cancer …, 2020 - academic.oup.com
Background Cisplatin-based chemotherapy may induce nephrotoxicity. This study presents a random forest predictive model that identifies testicular cancer patients at risk of …
Nephrotoxicity of cisplatin (CP) involves renal oxidative stress and inflammation, and sesamin (a major liganin in many plants) has strong antioxidant and antiinflammatory …
NA Samoylova, AP Gureev, VN Popov - International Journal of …, 2023 - mdpi.com
Cisplatin is a platinum-based cytostatic drug that is widely used for cancer treatment. Mitochondria and mtDNA are important targets for platinum-based cytostatics, which …
Radiotherapy can be employed as a therapeutic modality alone in the early stages of cancer and is used together with other treatments such as surgery and chemotherapy in more …
C Zhao, E Lu, X Hu, H Cheng, JA Zhang… - Cancer management …, 2018 - Taylor & Francis
Objective Our previous research has shown that the expression of S100 calcium-binding protein A9 (S100A9) in tumor cells was associated with neoadjuvant chemotherapy …